Ryo KATO
2Patents
0h-index
18Co-inventors
28Inventor score
Filing activity: Jul 23, 2019 → May 7, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12037345B2 | Heterobicyclic compounds for inhibiting the activity of SHP2 | Chemistry; Metallurgy | 0 | Active |
| US11541104B2 | Method for preventing or treating osteoporosis, characterized by administering teriparatide or salt thereof at a frequency of twice a week | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.